Lilly: Ebglis, a prescription medicine for moderate to severe eczema (atopic… · Jul 31–Aug 1, 2026

New
Lilly

Lilly's campaign promotes Ebglis, a prescription medicine for moderate to severe eczema, by framing the condition as a time-stealer and offering Ebglis as a solution to help individuals reclaim their time.

Jul 31, 2026
First seen
Aug 1, 2026
Last seen
5
Reads
5
Shows
2
Active months
1:01
Avg. length

13-week activity

Public campaign reads by observed week

through Aug 12
5

Renewal signals

30 dayPending
60 dayPending
90 dayPending
Promo-code persistence

No recurring promo code was observed.

Core offer

Ebglis, a prescription medicine for moderate to severe eczema (atopic dermatitis) for adults and children 12 and older.

Creative angle

Problem-solution frame emphasizing how the product helps reclaim time and control from eczema.

Representative reads

Examples across the campaign

Example transcript

The read that best represents this campaign's recurring script

View promo
Alan Carr's 'Life's a Beach'·S10 EP27: Sally Phillips
Est. value ~$240range $36$1.7K
Roland, you may not know this, but I have eczema, so I get how it can steal your time. But why let eczema take over when you can talk to your doctor about ebglis? Ebglis, Lubrikizumab LBKZ, a 250 milligram per two milliliter injection, is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds or 40 kilograms with moderate to severe eczema, also called atopic dermatitis that is not well controlled with prescription therapies used on the skin or topicals or who cannot use topical therapies. EBCLIS can be used with or without topical corticosteroids. Don't use if you are allergic to EBCLIS. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with EBCLIS. Before starting EBCLIS, tell your doctor if you have a parasitic infection. Paid partnership with Lilly. Respect your time. Ask your doctor about EBCLIS and visit EBCLIS.com or call 1-800-LILLY-RX or 1-800-545-5979.

These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.